FRESCI / Services
NAM Strategy and Adoption
Clarify the intended use, assess the evidence and identify the next steps for partnering, adoption or an institutional programme.
For teams developing, adopting or supporting new approach methodologies. Start with the decision ahead—not a generic assessment of an entire technology.
NAM Evidence and Adoption Review
Understand what your NAM evidence supports before your next decision.
Who it is for
A method developer preparing for partnering or review, or a biomedical team deciding whether to adopt a method.
What you receive
- Defined Context of Use and the decision to be supported
- Evidence-and-claim matrix with source links and limitations
- Prioritised gaps and implications for adoption
- 90-day action plan and a decision discussion
What we need to scope the work
Your available evidence dossier, current claims, intended use, scientific contact, decision and deadline. The source corpus is agreed before work begins.
Scope and delivery
A bounded review with an agreed scope, fee, timetable and review arrangements.
The review does not include experimental validation, formal regulatory representation or a guarantee of external acceptance.
Request a NAM review scopeNAM Evidence and Policy Programme
Build the evidence and stakeholder understanding needed for your programme.
Who it is for
An institution, research network, foundation or programme owner commissioning a scientific evidence study.
What you receive
- Specified evidence map or synthesis
- Documented method, coverage and limitations
- Stakeholder analysis or consultation when commissioned
- Recommendations and implementation priorities
What we need to scope the work
Terms of reference, decision owner, scope, sources, access requirements and review arrangements.
Scope and delivery
A commissioned study or phased programme, including delivery against a tender specification when applicable.
Scientific and strategic work—not a regulator’s decision or authority to represent an institution. Consultation is included only when commissioned.
Discuss an evidence programme